Email ID
Password
Sign me in automatically next time
Scrip Regulatory Affairs
Canada consults on plans to schedule device company inspections based on risk
12 August 2011
Vibha Sharma

Health Canada is seeking feedback from stakeholders on its plans to establish a risk-based approach for deciding how frequently medical device establishments should undergo inspections1.

In a consultation document on inspection cycles, the regulator describes four potential options for scheduling medical device inspections...

Please login to read the full article.
 
 
 
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
   
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36